Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Protein oxidation in Huntington disease.

Sorolla MA, Rodríguez-Colman MJ, Vall-llaura N, Tamarit J, Ros J, Cabiscol E.

Biofactors. 2012 May-Jun;38(3):173-85. doi: 10.1002/biof.1013. Review.

PMID:
22473822
2.

Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism.

Sorolla MA, Rodríguez-Colman MJ, Tamarit J, Ortega Z, Lucas JJ, Ferrer I, Ros J, Cabiscol E.

Free Radic Biol Med. 2010 Aug 15;49(4):612-21. doi: 10.1016/j.freeradbiomed.2010.05.016.

PMID:
20639122
3.

Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E.

Free Radic Biol Med. 2008 Sep 1;45(5):667-78. doi: 10.1016/j.freeradbiomed.2008.05.014.

PMID:
18588971
4.

Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease.

Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA.

Mol Cell Proteomics. 2005 Dec;4(12):1849-61.

5.

Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.

Sorolla MA, Nierga C, Rodríguez-Colman MJ, Reverter-Branchat G, Arenas A, Tamarit J, Ros J, Cabiscol E.

Arch Biochem Biophys. 2011 Jun 1;510(1):27-34. doi: 10.1016/j.abb.2011.04.002.

PMID:
21513696
6.

Huntington's disease: pathogenesis to animal models.

Kumar P, Kalonia H, Kumar A.

Pharmacol Rep. 2010 Jan-Feb;62(1):1-14. Review.

7.

Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease.

van Roon-Mom WM, Pepers BA, 't Hoen PA, Verwijmeren CA, den Dunnen JT, Dorsman JC, van Ommen GB.

BMC Mol Biol. 2008 Oct 9;9:84. doi: 10.1186/1471-2199-9-84.

8.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
9.

Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.

Stack EC, Matson WR, Ferrante RJ.

Ann N Y Acad Sci. 2008 Dec;1147:79-92. doi: 10.1196/annals.1427.008. Review.

PMID:
19076433
10.

Huntington disease: new insights into the relationship between CAG expansion and disease.

Nasir J, Goldberg YP, Hayden MR.

Hum Mol Genet. 1996;5 Spec No:1431-5. Review.

11.

Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation.

Reynolds GP, Dalton CF, Tillery CL, Mangiarini L, Davies SW, Bates GP.

J Neurochem. 1999 Apr;72(4):1773-6.

12.

Replicating Huntington's disease phenotype in experimental animals.

Brouillet E, Condé F, Beal MF, Hantraye P.

Prog Neurobiol. 1999 Dec;59(5):427-68. Review.

PMID:
10515664
13.

Recent advances on the pathogenesis of Huntington's disease.

Petersén A, Mani K, Brundin P.

Exp Neurol. 1999 May;157(1):1-18. Review.

PMID:
10222105
14.

Huntington's disease, calcium, and mitochondria.

Giacomello M, Hudec R, Lopreiato R.

Biofactors. 2011 May-Jun;37(3):206-18. doi: 10.1002/biof.162. Review.

PMID:
21674644
15.

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA.

J Neurochem. 2002 Sep;82(6):1524-32.

16.

In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.

Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, Déglon N, Ferrante RJ, Bonvento G.

Hum Mol Genet. 2010 Aug 1;19(15):3053-67. doi: 10.1093/hmg/ddq212.

17.

Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.

Perrin V, Régulier E, Abbas-Terki T, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Déglon N.

Mol Ther. 2007 May;15(5):903-11.

PMID:
17375066
18.

Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.

Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, Li XJ.

J Neurosci. 2003 Mar 15;23(6):2193-202.

20.

Early autophagic response in a novel knock-in model of Huntington disease.

Heng MY, Duong DK, Albin RL, Tallaksen-Greene SJ, Hunter JM, Lesort MJ, Osmand A, Paulson HL, Detloff PJ.

Hum Mol Genet. 2010 Oct 1;19(19):3702-20. doi: 10.1093/hmg/ddq285.

Items per page

Supplemental Content

Support Center